Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-018327
Filing Date
2025-02-27
Accepted
2025-02-27 17:24:52
Documents
17
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm257214d1_s8.htm S-8 57156
2 EXHIBIT 5.1 tm257214d1_ex5-1.htm EX-5.1 5044
3 EXHIBIT 23.1 tm257214d1_ex23-1.htm EX-23.1 2166
4 EX-FILING FEES tm257214d1_ex-filingfees.htm   iXBRL EX-FILING FEES 18339
5 GRAPHIC tm257214d1_ex5-1img001.jpg GRAPHIC 20994
6 GRAPHIC tm257214d1_ex5-1img002.jpg GRAPHIC 24745
  Complete submission text file 0001104659-25-018327.txt   285976

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm257214d1_ex-filingfees_htm.xml XML 8659
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285377 | Film No.: 25680933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)